Transforming Science into Medicine
아이디언스 항암제 후보물질 IDX-1197 美FDA IND 통과
아이디언스, 330억원 투자유치 성공
Idience is a science-driven biopharmaceutical company that changes oncology patients’ quality of life.
Meet the leadership team at Idience
Join our team if you share our values, our dedication to patients and our passion for science
Learn about our key pipeline of PARP inhibitor
Explore our clinical trials of PARP inhibitor